Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Coeptis Therapeutics Holdings (COEPW) Invested Capital (2021 - 2025)

Coeptis Therapeutics Holdings has reported Invested Capital over the past 5 years, most recently at $14.1 million for Q4 2025.

  • Quarterly results put Invested Capital at $14.1 million for Q4 2025, up 218.02% from a year ago — trailing twelve months through Dec 2025 was $14.1 million (up 218.02% YoY), and the annual figure for FY2025 was $14.1 million, up 218.02%.
  • Invested Capital for Q4 2025 was $14.1 million at Coeptis Therapeutics Holdings, up from $10.4 million in the prior quarter.
  • Over the last five years, Invested Capital for COEPW hit a ceiling of $14.1 million in Q4 2025 and a floor of -$9.7 million in Q2 2021.
  • Median Invested Capital over the past 5 years was $2.2 million (2022), compared with a mean of $2.4 million.
  • Biggest five-year swings in Invested Capital: crashed 234.76% in 2024 and later surged 2383.47% in 2025.
  • Coeptis Therapeutics Holdings' Invested Capital stood at $2.4 million in 2021, then surged by 89.45% to $4.5 million in 2022, then crashed by 81.72% to $813963.0 in 2023, then surged by 443.47% to $4.4 million in 2024, then skyrocketed by 218.02% to $14.1 million in 2025.
  • The last three reported values for Invested Capital were $14.1 million (Q4 2025), $10.4 million (Q3 2025), and $7.1 million (Q2 2025) per Business Quant data.